JOST Werke (JST) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
13 May, 2026Executive summary
Achieved record Q1 2026 sales of €417 million, up 11.6%-12% year-over-year, with all regions and business lines contributing to 9% organic growth and strong performance in Agriculture and Hydraulics.
Adjusted EBIT increased 23% to €44.1 million, with margin reaching 10.6%, achieving strategic profitability targets one year after the Hyva acquisition.
Hyva integration progressing well, delivering synergies, supporting profitability, and returning margin to the strategic corridor earlier than planned.
10% capital increase in Q1 2026, issuing 1.49 million shares at €62.13 per share, raising approximately €92.6–93 million gross, used to strengthen equity and repay short-term debt.
Inaugurated a new hydraulics plant in Brazil, expanding capacity and regional footprint in the Americas.
Financial highlights
Revenue: €417.0 million (+11.6%–12% YoY); organic growth 9% after adjusting for acquisitions and currency effects.
Adjusted EBIT: €44.1 million (+23% YoY); margin 10.6% (+1.0pp YoY), within the strategic corridor.
Adjusted net income grew 17% to €28.3 million; adjusted EPS up 12% to €1.81 despite higher share count.
Reported net income up 26% to €16.5 million; reported EPS at €1.05.
Free cash flow slightly negative at €-1.6 million, mainly due to higher working capital and safety stock buildup.
Outlook and guidance
2026 revenue expected to grow by a single-digit percentage, with adjusted EBIT to increase by a mid- to high single-digit percentage, outpacing sales growth.
Adjusted EBIT margin for 2026 projected to exceed 2025’s 9.5%, supported by further Hyva synergies.
CapEx expected at 2.8% of sales; working capital targeted at 17.5%-18.5% of sales.
Cautious outlook due to macro and geopolitical uncertainties, especially the Iran conflict and energy price volatility.
Latest events from JOST Werke
- Sales up 44% and adjusted EBIT up 29% in 2025, with further gains targeted for 2026.JST
Q4 202529 Mar 2026 - Strong 2025 growth, digital innovation, and Hyva integration drive ambitious 2030 targets.JST
Investor presentation5 Mar 2026 - Margins and cash flow improved despite sales decline; 2024 guidance confirmed.JST
Q2 20242 Feb 2026 - Acquisitions and expansion add €100m in sales and boost agricultural market reach.JST
Investor Update22 Jan 2026 - Targets €2B+ sales, €10 EPS, and 10–12% EBIT margin by 2030, driven by innovation and M&A.JST
CMD 202421 Jan 2026 - Acquisition targets EUR 23–28m synergies, expands global reach, and closes in Q4 2024.JST
M&A Announcement20 Jan 2026 - Despite sales declines, strong cash flow and key acquisitions support future growth.JST
Q3 202414 Jan 2026 - Hyva acquisition to drive 50–60% sales growth and margin expansion in 2025.JST
Q4 202417 Dec 2025 - Q2 2025 sales up 31% on Hyva deal, with 2025 outlook reaffirmed despite margin pressure.JST
Q2 202523 Nov 2025